Class A
Instructions for Ambroxol Hydrochloride Dispersible Tablets
Please read the instructions carefully and use according to the instructions or buy and use under the guidance of a pharmacist.
Drug Name
Generic Name: Ambroxol Hydrochloride Dispersible Tablets
Trade Name: Lactamycin®
English name: Ambroxol Hydrochloride Dispersible Tablets
Hanyu Pinyin: Yansuan Anxiusuo Fensanpian
Ingredients
Each tablet contains 30 mg of Ambroxol Hydrochloride and is supplemented by lactose, microcrystalline cellulose, cross-linked povidone, aspartame and magnesium stearate.
Properties
This product is white or off-white tablet.
Class of action
This product is an over-the-counter drug in the category of expectorant medicine.
Indications
For people with thick sputum that cannot be easily coughed up.
Specification】30mg
Dosage]
Take orally. It can be taken orally after dispersing with water, or by sucking or swallowing the tablets in the mouth. For adults, take 1 to 2 tablets once, 3 times a day after meals.
Adverse reactions]
Rash, nausea, stomach upset, lack of appetite, abdominal pain, diarrhea may be seen occasionally.
Other allergic reactions, including anaphylaxis, angioedema, urticaria, and pruritus.
Other gastrointestinal reactions, such as gastrointestinal dysfunction, including vomiting and dyspepsia.
Other neurological reactions, including headache and dizziness.
Rare serious skin reactions, including erythema multiforme, Stevens-Johnson syndrome (SJS)/toxic epidermolysis bullosa (TEN), and acute generalized eruptive impetigo.
If serious adverse reactions occur, discontinue treatment immediately.
Contraindications
Not recommended for those with known hypersensitivity to Ambroxol Hydrochloride or other components of this product.
Contraindicated in women during the first 3 months of pregnancy.
Precautions
1. This product is not recommended for pregnant and lactating women; if necessary, use with caution as directed by a physician and is contraindicated in the first trimester of pregnancy.
2. Consult your physician or pharmacist for dosage for children.
3. Avoid using it together with central cough suppressants (such as dextromethorphan, etc.) to avoid blocking the airway with diluted sputum.
4. This product is a mucus regulator and only has a certain effect on the coughing symptoms. When using it, please pay attention to the cause of coughing and coughing sputum.
5. If overdose or serious adverse reactions occur, seek medical attention immediately.
6. It is prohibited for those who are allergic to this product and should be used with caution for those who are allergic.
7. The use of this product is prohibited when its properties change.
8. Keep this product out of the reach of children.
9. Children must be used under adult supervision.
10. If you are using other drugs, consult your physician or pharmacist before using this product.
11. A few cases of severe skin damage, such as Stevens-Johnson syndrome and toxic epidermolysis bullosa, have been reported in association with the duration of expectorant medication (e.g., tranylcypromine hydrochloride). Most of these cases can be explained by the severity of the patient’s underlying disease and/or the combination of medications. In addition, in the early stages of Stevens-Johnson syndrome or toxic epidermolysis bullosa, patients may first present with nonspecific influenza-like prodromal symptoms such as fever, body aches, rhinitis, cough, and sore throat. These nonspecific flu-like prodromal symptoms can be misleading and may begin with symptomatic treatment with cough and cold medications. Therefore, if new skin or mucosal lesions develop, seek immediate medical attention and, as a precautionary measure, discontinue the use of Ambroxol Hydrochloride.
12. For patients with impaired renal function, this product should be used only after consultation with a physician.
13. This product contains 78 mg of lactose per tablet and should not be taken by patients with rare hereditary galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption.
14. This product has no effect on driving and mechanical ability.
Drug Interaction]
1.This product and antibiotics (amoxicillin, cefuroxime, erythromycin, doxycycline) taken at the same time may lead to an increase in the concentration of antibiotics in lung tissue.
2. Drug interactions may occur if used together with other drugs, please consult your physician or pharmacist for details.
Pharmacological effects]
This product is a mucolytic agent, which can increase the secretion of respiratory mucous membrane plasma glands and reduce the secretion of mucus glands, thus reducing the viscosity of sputum, promoting the secretion of lung surface active substances, increasing the movement of bronchial cilia and making sputum easy to cough up.
Storage]
Keep sealed.
Package】
Double aluminum packaging made of polyester/aluminum/polyethylene pharmaceutical packaging film, 10 tablets/plate x 1 plate/box; 10 tablets/plate x 2 plates/box; 10 tablets/plate x 3 plates/box; 10 tablets/plate x 5 plates/box.
Expiration date
18 months
【Execution standard
/
Approval number
State Drug Certification H20060254
Date of revision of instruction
Manufacturer
Company Name: Shanxi Qian Yuan Pharmaceutical Group Co.
Production Address: No. 53, Hubin Street, Datong Economic and Technological Development Zone, Shanxi Province
Postal Code：037010
Telephone number: 0352-6116505
Fax number: 0352-6116515
Web address: http://www.cy-pharm.com
If you have any questions, please contact with the manufacturer